These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33844424)

  • 21. Impact of the 18th birthday on waitlist outcomes among young adults listed for heart transplant: A regression discontinuity analysis.
    Peng DM; Qu Q; McDonald N; Hollander SA; Bernstein D; Maeda K; Kaufman BD; Rosenthal DN; McElhinney DB; Almond CS
    J Heart Lung Transplant; 2017 Nov; 36(11):1185-1191. PubMed ID: 28712678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group.
    Morrow WR; Naftel D; Chinnock R; Canter C; Boucek M; Zales V; McGiffin DC; Kirklin JK
    J Heart Lung Transplant; 1997 Dec; 16(12):1255-66. PubMed ID: 9436138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparities in Wait-List Outcomes for Adults With Congenital Heart Disease Listed for Heart Transplantation Before and Since Revision of Status I Listing.
    Alshawabkeh L; Opotowsky AR; Carter KD; Givertz MM; Landzberg MJ; Urey MA; Bartlett H
    Am J Cardiol; 2018 Nov; 122(10):1761-1764. PubMed ID: 30236623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration.
    De Meester J; Smits JM; Persijn GG; Haverich A
    J Heart Lung Transplant; 1999 Jun; 18(6):563-71. PubMed ID: 10395354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of listing for lung and heart-lung transplantation in pulmonary hypertension: comparative experience in France and the UK.
    Pradère P; Le Pavec J; Bos S; Pozza A; Nair A; Meachery G; Lordan J; Humbert M; Mercier O; Fadel E; Savale L; Fisher AJ
    ERJ Open Res; 2024 Jan; 10(1):. PubMed ID: 38259809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival on the Heart Transplant Waiting List.
    Bakhtiyar SS; Godfrey EL; Ahmed S; Lamba H; Morgan J; Loor G; Civitello A; Cheema FH; Etheridge WB; Goss J; Rana A
    JAMA Cardiol; 2020 Nov; 5(11):1227-1235. PubMed ID: 32785619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States.
    Krishnamurthy Y; Cooper LB; Lu D; Schroder JN; Daneshmand MA; Rogers JG; Milano CA; Hernandez AF; Patel CB
    J Heart Lung Transplant; 2016 May; 35(5):619-24. PubMed ID: 26856668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation.
    Nativi JN; Kfoury AG; Myrick C; Peters M; Renlund D; Gilbert EM; Bader F; Singhal AK; Everitt M; Fisher P; Bull DA; Selzman C; Stehlik J
    J Heart Lung Transplant; 2010 Mar; 29(3):235-9. PubMed ID: 19782588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The modified US heart allocation system improves transplant rates and decreases status upgrade utilization for patients with hypertrophic cardiomyopathy.
    Fowler CC; Helmers MR; Smood B; Iyengar A; Patrick W; Alan Herbst D; Altshuler P; Han JJ; Kelly J; Atluri P
    J Heart Lung Transplant; 2021 Oct; 40(10):1181-1190. PubMed ID: 34332861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inferior Outcomes on the Waiting List in Low-Volume Pediatric Heart Transplant Centers.
    Rana A; Fraser CD; Scully BB; Heinle JS; McKenzie ED; Dreyer WJ; Kueht M; Liu H; Brewer ED; Rosengart TK; O'Mahony CA; Goss JA
    Am J Transplant; 2017 Jun; 17(6):1515-1524. PubMed ID: 28251816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of ABO-incompatible listing on wait-list outcomes among infants listed for heart transplantation in the United States: a propensity analysis.
    Almond CS; Gauvreau K; Thiagarajan RR; Piercey GE; Blume ED; Smoot LB; Fynn-Thompson F; Singh TP
    Circulation; 2010 May; 121(17):1926-33. PubMed ID: 20404257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A current era analysis of ABO incompatible listing practice and impact on outcomes in young children requiring heart transplantation.
    Urschel S; McCoy M; Cantor RS; Koehl DA; Zuckerman WA; Dipchand AI; Reinhardt Z; Kanter KR; Ballweg JA; Sparks J; Kirklin JK; Carlo WF
    J Heart Lung Transplant; 2020 Jul; 39(7):627-635. PubMed ID: 32201088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Listing Low-Weight or Ill Infants for Heart Transplantation: Is It Prudent?
    Rizwan R; Zafar F; Chin C; Tweddell J; Bryant R; Morales D
    Ann Thorac Surg; 2018 Oct; 106(4):1189-1196. PubMed ID: 30009801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A change of heart: Preliminary results of the US 2018 adult heart allocation revision.
    Goff RR; Uccellini K; Lindblad K; Hall S; Davies R; Farr M; Silvestry S; Rogers JG
    Am J Transplant; 2020 Oct; 20(10):2781-2790. PubMed ID: 32406597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paediatric heart transplantation in Australia comes of age: 21 years of experience in a national centre.
    Alexander PM; Swager A; Lee KJ; Shipp A; Konstantinov IE; Wilkinson JL; d'Udekem Y; Brizard C; Weintraub RG
    Intern Med J; 2014 Dec; 44(12a):1223-31. PubMed ID: 25169621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung transplantation for chronic obstructive pulmonary disease: A call to modify the lung allocation score to decrease waitlist mortality.
    Hull TD; Leya GA; Axtell AL; Moonsamy P; Osho A; Chang DC; Sundt TM; Villavicencio MA
    J Thorac Cardiovasc Surg; 2022 Oct; 164(4):1222-1233.e11. PubMed ID: 35016781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.
    Vicaire H; Pavec JL; Mercier O; Montani D; Boucly A; Roche A; Pradère P; Dauriat G; Feuillet S; Pichon J; Jevnikar M; Beurnier A; Jaïs X; Fadel E; Sitbon O; Humbert M; Savale L
    J Heart Lung Transplant; 2022 Sep; 41(9):1285-1293. PubMed ID: 35778258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The heart transplant allocation change attenuates but does not eliminate blood group O waitlist outcome disadvantage.
    Patel JN; Abramov D; Fudim M; Okwuosa IS; Rabkin DG; Chung JS
    Clin Transplant; 2022 May; 36(5):e14620. PubMed ID: 35213753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?
    Winkel E; Kao W; Fisher SG; Heroux AL; Johnson MR; Costanzo MR
    J Heart Lung Transplant; 1998 Aug; 17(8):809-16. PubMed ID: 9730431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.